Noninvasive Prediction of Occult Peritoneal Metastasis in Gastric Cancer Using Deep Learning

Yuming Jiang(Nanfang Hospital), Ruijiang Li(Capital Medical University), Hao Chen(Nanfang Hospital), Zhiwei Zhou(Sun Yat-sen University), Xiaokun Liang(University of Chinese Academy of Sciences), Guoxin Li(Nanfang Hospital), Yaoqin Xie(Shenzhen Institutes of Advanced Technology), Chuanli Chen(Nanfang Hospital), Na Li(Shenzhen Institutes of Advanced Technology), Xiaodong Zhang(Third Affiliated Hospital of Southern Medical University), Wei Wang(Sun Yat-sen University), Jiang Yu(Southern Medical University), Yikai Xu(Southern Medical University), Qingyu Yuan(Nanfang Hospital)
JAMA Network Open
January 5, 2021
10.1001/jamanetworkopen.2020.32269
Cited by 117

Related Papers

Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer
|JAMA Oncology|2017|600
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
A pathology foundation model for cancer diagnosis and prognosis prediction
|Nature|2024|421